Compare ADMA Biologics Inc (ADMA) vs Snap On Incorporated (SNA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ADMA Biologics Inc vs Snap On Incorporated — how do they compare? ADMA Biologics Inc trades at $9.81 (market cap $2.22B), while Snap On Incorporated trades at $412.41 (market cap $21.30B). The key difference: Snap On Incorporated is far larger — about 9.6× ADMA Biologics Inc's market cap, and Snap On Incorporated pays a 2.37% dividend while ADMA Biologics Inc pays none. Which is the better fit depends on your goals.
| ADMA | SNA | |
|---|---|---|
Market Cap | $2.22B | $21.30B |
Sector | Health | Technology |
52-Week High | $20.38 | $419.31 |
52-Week Low | $7.60 | $321.38 |
Enterprise Value | $2.29B | $20.93B |
Dividend Yield | — | 2.37% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ADMA Biologics Inc
ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.
Read more on ADMA →About Snap On Incorporated
Snap-on Incorporated is a leading global innovator, manufacturer, and marketer of tools, equipment, diagnostics, repair information, and systems solutions for professional users. Its products are widely used in vehicle service and repair, as well as in other demanding industrial environments. The company is best known for its premium tool brand, often sold through a network of franchised mobile stores, and is a primary supplier to technicians in the transportation industry.
Read more on SNA →
